Company Filing History:
Years Active: 2023
Title: Adelle A Vandersteen: Innovator in Pharmaceutical Formulations
Introduction
Adelle A Vandersteen is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of inhalation therapies. Her work focuses on innovative solutions for treating viral infections, showcasing her dedication to improving healthcare outcomes.
Latest Patents
Adelle holds a patent for "Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs." This patent provides pharmaceutical formulations of specific compounds and their pharmaceutically acceptable salts, designed for administration by inhalation. The formulations are particularly useful in the treatment and prevention of viral infections in subjects who require such interventions.
Career Highlights
Adelle is currently associated with Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on antiviral drugs. Her role at Gilead has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout her career, Adelle has collaborated with talented professionals, including Scott Ellis and Davin S Rautiola. These collaborations have further enhanced her innovative work and contributed to the success of her projects.
Conclusion
Adelle A Vandersteen's contributions to pharmaceutical formulations exemplify her commitment to advancing medical science. Her innovative approaches in treating viral infections highlight the importance of research and development in healthcare.